Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Sep 15;15:637. doi: 10.1186/s12885-015-1637-7

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Li et al. 2015

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 1 — Comparison of MAWBP, MAWD, TGF-beta, E-cadherin, and PGC expression in GC and normal tissues by using IHC. (a) Comparison of MAWBP and MAWD expression in GC and normal tissues by means of TMA and IHC analysis (100×; 400× in the lower right corner). Weak MAWBP (a) and MAWD (b) protein staining in poorly differentiated carcinoma; expression of MAWBP (c) and MAWD (d) in intestinal metaplasia; strong positive staining of MAWBP (e) and MAWD (f) in normal tissues (P < 0.001). (b) Kaplan–Meier analysis of overall survival in GC patients expressing different levels of MAWBP and MAWD. (a) Green and blue lines represent the survival curves of patients expressing high and low levels of MAWBP (P < 0.05). (b) Green and blue lines represent the survival curves of patients expressing MAWD at high and low levels (P < 0.05). (c) Combined MAWBP and MAWD expression for analysis of overall survival; prognosis was better for patients who expressed high levels of MAWBP and MAWD than for patients who expressed the proteins at low levels (P < 0.05). (c) Comparison of TGF-beta, E-cadherin, and PGC expression in GC and normal tissues by using TMA and IHC analysis (100×; 400× in the lower right corner). Weak TGF-beta (a), E-cadherin (b), and PGC (c) protein staining in poorly differentiated carcinoma; staining for TGF-beta (d), E-cadherin (e), and PGC (f) in intestinal metaplasia; strong positive staining for TGF-beta (g), E-cadherin (h), and PGC (i) in normal tissues (P < 0.05)